U.S. markets closed
  • S&P 500

    4,443.11
    -12.37 (-0.28%)
     
  • Dow 30

    34,869.37
    +71.37 (+0.21%)
     
  • Nasdaq

    14,969.97
    -77.73 (-0.52%)
     
  • Russell 2000

    2,281.00
    +32.93 (+1.46%)
     
  • Crude Oil

    75.37
    -0.08 (-0.11%)
     
  • Gold

    1,750.40
    -1.60 (-0.09%)
     
  • Silver

    22.64
    -0.05 (-0.24%)
     
  • EUR/USD

    1.1699
    -0.0003 (-0.02%)
     
  • 10-Yr Bond

    1.4840
    +0.0240 (+1.64%)
     
  • GBP/USD

    1.3704
    -0.0001 (-0.00%)
     
  • USD/JPY

    110.9920
    +0.0140 (+0.01%)
     
  • BTC-USD

    42,799.06
    -215.52 (-0.50%)
     
  • CMC Crypto 200

    1,062.43
    -39.09 (-3.55%)
     
  • FTSE 100

    7,063.40
    +11.92 (+0.17%)
     
  • Nikkei 225

    30,240.06
    -8.75 (-0.03%)
     

NRx and Israel Developing Covid-19 Vaccine to Attack Variants

Aug.30 -- NRx Pharmaceuticals CEO Dr. Jonathan Javitt says they are working with Israel on a Covid-19 vaccine that targets Covid variants. He says vaccines from last year are becoming less effective. He's on "Bloomberg Markets."